| | |
PTI 05:58 PM | September 29,2009
In India, it takes eight months in getting nod for conducting clinical trials by pharma companies which puts the Indian firms at disadvantageous position against their counterparts in developed countries
|
|
C.H. Unnikrishnan 12:47 AM | June 18,2009
Advinus is working with two multinational drug companies to develop drugs for other diseases
|
|
C.H. Unnikrishnan 11:39 PM | May 14,2009
An earlier audit by the regulator had found the trial had violated protocols, standard operating procedures and norms on good clinical practices listed in the country’s drugs law
|
|
PTI 10:29 PM | March 12,2009
During the audits, glaring deficiencies have been found as the sponsors, monitors and CROs do not adhere to protocols
|
|
C.H. Unnikrishnan 10:23 PM | February 19,2009
There have also been instances of negligence by researchers and exploitation of uninformed patients
|
|
Natasha Singer / NYT 10:03 PM | February 19,2009
The report also asks whether drug research conducted in developing countries is relevant to the treatment of American patients
|
|
PTI 06:32 PM | December 12,2008
The company recently got approval of DCGI for initiating phase-I clinical trials in India for its new diabetic drug, which is already being tested in the Netherlands
|
|
01:41 PM | June 15,2008
The report noted Indian companies are playing a strategic role in early drug discovery processes due to their vast experience in the field of generic drugs
|
|
10:56 AM | June 11,2008
TB is a leading causes of mortality in India with over 1,000 dying daily; the grant would be used to support scientific infrastructure development and clinical trials for new vaccines
|
|
Bharghavi Nagaraju/Reuters 01:25 AM | February 19,2008
Currently, only companies doing in-house research are eligible for tax breaks of up to 150% of their research expense
|
|
PTI 06:02 PM | December 17,2007
Fluency in English, high quality of medical personnel, lower costs and high availability of patients to conduct the research and trials is turning India a preferred destination
|
|
C.H.Unnikrishnan 11:14 PM | November 26,2007
The company is currently equipped to handle services such as informatics, chemical synthesis, discovery, clinical trials
|
|
Reuters 11:57 AM | November 19,2007
While Nicholas Piramal will carry out human clinical trials, Merck has the option to advance the drug candidates to late stage clinical trials and commercialize them
|
|
C.H. Unnikrishnan 12:21 AM | August 23,2007
One option under consideration is to expand Ranbaxy’s partnership model in core drug discovery research
|
|
C.H. Unnikrishnan 12:27 AM | June 26,2007
Union health ministry is set to bring these trials under the proposed Central Drugs Authority law
|
|